Adicet Bio, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number
Adicet Bio, Inc. (ACET) had Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of 70.66 thousand shares as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber · last filed 2026-08-05
- 2026-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 70.66K shares.
- 2026-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 74.50K shares.
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 46.84K shares.
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 759.77K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number as first filed |
|---|---|---|
| 2026-06-30 | 70.66K shares 10-Q · filed 2026-08-05 | |
| 2026-03-31 | 74.50K shares 10-Q · filed 2026-05-13 | |
| 2025-12-31 | 46.84K shares 10-Q · filed 2026-08-05 | |
| 2025-09-30 | 759.77K shares 10-Q · filed 2025-11-05 | |
| 2025-06-30 | 902.12K shares 10-Q · filed 2025-08-07 | |
| 2025-03-31 | 914.25K shares 10-Q · filed 2025-05-06 | |
| 2024-12-31 | 44.95K shares 10-K · filed 2026-03-12 | 719.66K shares 10-K · filed 2025-03-06 |
| 2024-09-30 | 765.86K shares 10-Q · filed 2024-11-06 | |
| 2024-06-30 | 782.79K shares 10-Q · filed 2024-08-13 | |
| 2024-03-31 | 791.42K shares 10-Q · filed 2024-05-14 | |
| 2023-12-31 | 454.20K shares 10-K · filed 2025-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |